Study physician for a pivotal phase 3 study with pegcetacoplan;
Engagement with key external experts and investigators;
Participate in the design, conduct and report of Sobi-sponsored studies;
Clinical development expertise in regulatory submissions and interactions with regulatory and reimbursement authorities;
Medical expert support to other functions within Sobi on matters relating to hematology including regulatory, drug safety and business development.
MD., preferable board certified haematologist;
Solid record of accomplishments in drug development programs within haematology as study physician demonstrating outstanding and intimate understanding of translating early stage programs into the clinic and further across the clinical development chain;
Good communication skills, capable of representing the company to all audiences both internally and externally, particularly in the context of collaborations with partners and key external experts;
Fluent in English.
Good organizational skills, be a self-motivated driver of best practices and processes in the management of projects and operations;
Good team-player with high personal and scientific integrity;
Comfortable working in fast paced environment;
You are able to demonstrate behaviors in line with Sobi’s core values: Care, Ambition, Urgency, Ownership and Partnership.